Fig. 2: Volumetric changes of treatment naive OCT biomarkers under anti-VEGF treatment.

Significant reduction was seen in IRF, SRF, SHRM, RPE and central foveal thickness.
Significant reduction was seen in IRF, SRF, SHRM, RPE and central foveal thickness.